Novavax Analyst Sees Leading Contender In Coronavirus Vaccine Race
Mastercraft Boat Rides Upgrade After Analyst Is 'Increasingly Confident' Demand Is Intact
Novavax Analyst Sees Leading Contender In Coronavirus Vaccine Race
Mastercraft Boat Rides Upgrade After Analyst Is 'Increasingly Confident' Demand Is Intact
Novavax Analysts Say CEPI Funding 'Speaks Volumes' About Coronavirus Vaccine Development
Spectrum Pharma Analyst Says Sell-Off May Have Been Overdone
B Riley FBR Recent News
The Midterm Election: What 3 Pros Expect
Recent Assembly Biosciences Weakness Provides Attractive Entry Point, B Riley FBR Says In Upgrade
FBR: Novavax Looks Healthy Ahead Of Catalysts
Ahoy, Upside Ahead: B Riley FBR Out Bullish On 3 Shipping Stocks
Analysts React To Weight Watcher's Q2 Earnings
Pluristem Therapuetics, Rexahn Pharma Are Biotech Winners, B Riley FBR Says In Bullish Initiation
Columbia Sportswear Downgraded Ahead Of Q2 Print
Farmland Partners Loans Are 'Concerning, But Immaterial,' Analyst Says In Upgrade
Broadcom Shares Plummet After Wall Street Questions Sudden Acquisition Strategy
Analyst: Tetra Technologies Is An 'EBITDA Engine'
Analyst Downgrades Arbutus Biopharma On Valuation After 80% Run
B. Riley FBR: 3 Reasons To Buy Alimera Sciences
3 Reasons Why Uniqure Could Overtake Hemophilia B Virus Gene Therapy
Deciphera Pharma Hit With Sell-Side Downgrade On Valuation After 50% Gain
HomeStreet Cost Cuts Should Result In Higher 2019 Earnings, Analyst Says In Upgrade
Ramaco Resources Holds 25% Upside Potential, Analyst Says In Bullish Initiation
Analysts Applaud Intel's Q1 Beat-And-Raise, Say Delay In 10-Nanometer Chips A Negative
Analyst: Clementia Has Potential To Reach Unmet Market For Rare Bone Disease
Dicerna Pharma Has Multiple Pipeline Opportunities, Tough Competition, Analyst Says In Neutral Initiation
After Nvidia Analyst Day, Wall Street Talks AV Testing, Artificial Intelligence, GPUs
Main Street Capital Has The Ingredients For Superior Economic Return, Says B Riley FBR
JD Sports' $588-Million Finish Line Purchase Is Positive For Both Companies
BB&T Should Trade At Premium To Other Large-Cap Banks, Says B Riley FBR